Aloe vera leaf pulp has been utilized for over 5000 years as a medicinal plant by various civilizations, including the Egyptians, Romans, and Indigenous peoples of Africa, Asia, and the Americas [
1]. In contemporary times, it is employed for the treatment of skin infections and burns, digestive disorders, and immune system enhancement [
2]. The objective of this study was to investigate the anti-inflammatory and antioxidant activity of an aqueous extract of Aloe vera leaf pulp in immortalized human keratinocytes HaCaT to evaluate its biomedical potential for wound care management. Aloe vera gel powder obtained by leaf pulp freeze-drying was extracted in distilled water and then centrifuged. Preliminary compositional characterization consisted of the determination of total phenolic content by the Folin–Ciocalteu method, protein content using Bradford assay, and ascorbic acid content by the 2,6-dichlorophenolindophenol method. The assessment of in vitro cytocompatibility was performed in a stabilized cell line of human HaCaT keratinocytes treated with different concentrations of Aloe vera. Based on the results of the neutral red assay, the cytocompatible extract concentrations were selected and used in further in vitro tests. An experimental model in vitro mimicking the inflammatory and pro-oxidant milieu specific for skin wounds was developed using HaCaT cells cultivated in stress conditions by treatment with t-butyl hydroperoxide (t-BHP). After 24 h of cultivation in the presence of different concentrations of Aloe vera, the concentrations of the pro-inflammatory cytokine interleukin 8 (IL-8) secreted in the culture media were determined using a specific ELISA kit. In addition, the intracellular reactive oxygen species (ROS) production was quantified using a diacetyldichlorofluorescein assay, flow cytometry analysis, and histogram processing using FlowJo software v10.10. Statistical analysis was performed on control–sample pairs of interest. The following results were obtained in regard to chemical composition: total phenolic content of 3 mg gallic acid equivalents/g dry weight, 0.13 mg protein/g dry weight, and 0.39 mg ascorbic acid/g dry weight. Cell culture testing revealed that Aloe vera extract was cytocompatible within a wide range of concentrations between 0.1 and 1 mg/mL. In the wounded milieu model, the extract showed the capacity to inhibit IL-8 secretion at concentrations of 0.1 and 0.25 mg/mL (
Figure 1). Moreover, the extract inhibited the production of intracellular ROS at a concentration of 0.25 mg/mL as a result of high phenolic and ascorbic acid content. In summary, the findings of this study provided further evidence supporting the antioxidant and anti-inflammatory properties associated with Aloe vera gel in stressed HaCaT cell culture. As a result, this research demonstrated that Aloe vera gel could be used in the development of composite biomaterials that can be effectively applied in the treatment of skin lesions.
Author Contributions
Conceptualization and supervision, A.C. and O.C.; formal analysis, A.I., E.M. and A.-M.S.-G.; data curation, A.C., O.C. and L.M.S.; funding acquisition, O.C. and L.M.S.; writing original draft, A.I. and review and editing, A.I. All authors have read and agreed to the published version of the manuscript.
Funding
This study was supported by the Ministry of Research, Innovation and Digitization, Program Nucleu, contract no. PN 23 02/2023.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
The data presented in this study are available in this article.
Conflicts of Interest
The authors declare no conflicts of interest.
References
- Shedoeva, A.; Leavesley, D.; Upton, Z.; Fan, C. Wound healing and the use of medicinal plants. Evid. Based Complement. Alternat. Med. 2019, 2019, 2684108. [Google Scholar] [CrossRef]
- Harinatha Reddy, A.; Sri Lakshmi, B.; Nageswari, G.; Shobha, R.; Venkatappa, B. Phytochemical screening, TLC fingerprinting and antimicrobial activity of methanolic leaf extract of Aloe vera against clinical isolates of methicillin resistant Staphylococcus aureus. Mintage J. Pharm. Med. Sci. 2015, 5, 16–18. [Google Scholar]
| Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).